Janux Therapeutics (JANX) EBT Margin (2021 - 2026)
Janux Therapeutics (JANX) reported EBT Margin of 652.59% for Q1 2026, down 168.41% quarter-over-quarter from 243.13% in Q3 2025.
Janux Therapeutics (JANX) EBT Margin (2021 - 2026) Analysis & Trends
Janux Therapeutics (JANX) has 6 years of EBT Margin data on file, last reported at 652.59% in Q1 2026.
- EBT Margin for Q1 2026 came in at 652.59%, changed N/A year-over-year; the trailing twelve-month figure through Mar 2026 was 833.6% (down 89.0% YoY), and the FY2025 annual result was 1136.25%, down 48463.0% from the prior year.
- EBT Margin retreated to 652.59% in Q1 2026 per JANX's latest filing, from 243.13% in the prior quarter.
- Over five years, EBT Margin peaked at 66.98% in Q2 2024 and troughed at 6391.57% in Q3 2024.
- A 5-year average of 1155.62% and a median of 714.08% in 2022 frame the typical range for EBT Margin.
- The sharpest annual moves came in 2024 and 2025: EBT Margin plunged 593198 bps in 2024, then soared 614844 bps in 2025.
- A 5-year view of EBT Margin shows it stood at 564.67% in 2022, then gained by 15 bps to 477.77% in 2023, then sank by 1238 bps to 6391.57% in 2024, then surged by 96 bps to 243.13% in 2025, then plunged by 168 bps to 652.59% in 2026.
- Business Quant data shows JANX's EBT Margin at 652.59% in Q1 2026, 243.13% in Q3 2025, and 6391.57% in Q3 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 6.40% |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 41.95% |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Janux Therapeutics | 892.99 Mn | 892.99 Mn | - | -652.59% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -652.59% |
| Sep 30, 2025 | -243.13% |
| Sep 30, 2024 | -6,391.57% |
| Jun 30, 2024 | -66.98% |
| Mar 31, 2024 | -1,178.91% |
| Dec 31, 2023 | -477.77% |
| Sep 30, 2023 | -459.59% |
| Jun 30, 2023 | -1,656.39% |
| Mar 31, 2023 | -852.49% |
| Dec 31, 2022 | -564.67% |
| Sep 30, 2022 | -920.90% |
| Jun 30, 2022 | -714.08% |
| Mar 31, 2022 | -843.93% |
| Dec 31, 2021 | -830.20% |
| Sep 30, 2021 | -928.90% |
| Jun 30, 2021 | -1,287.55% |
| Mar 31, 2021 | -601.05% |